Medical Graphic

Education & Training

Christopher Mallavarapu, MD, FACC, SCAI is board certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology.

Christopher Mallavarapu's academic and clinical training spans some of the most respected institutions in American medicine. From his undergraduate studies through three specialized fellowships, his educational background reflects a sustained commitment to mastering every dimension of cardiovascular care.

Education
Dr. Mallavarapu's formal training is as follows:
  • Fellowship, Interventional Cardiology, University of Pennsylvania Health System, Philadelphia
    • Fellowship, Electrophysiology, University of Pennsylvania Health System, Philadelphia Fellowship, Clinical Cardiology, University of Pennsylvania Health System, Philadelphia
  • Residency, Internal Medicine, State University of New York at Stony Brook
  • Doctor of Medicine, State University of New York Downstate College of Medicine, Brooklyn, NY
  • Bachelor of Science, Chemistry, Creighton University, Omaha, Nebraska
Completing three distinct fellowships at the University of Pennsylvania Health System reflects a deliberate effort to develop deep expertise across clinical practice, electrophysiology, and interventional techniques simultaneously.

Certifications

Christopher Mallavarapu holds the following board certifications and professional designations:
  • Board Certified, Internal Medicine
  • Board Certified, Cardiovascular Disease
  • Board Certified, Interventional Cardiology
  • Fellow, American College of Cardiology (FACC) Fellow, Society for Cardiovascular Angiography and Interventions (SCAI)
  • Certified by the Council of Nuclear Cardiology
Together, these credentials represent one of the more comprehensive certification profiles in the field, covering the diagnostic, interventional, and nuclear dimensions of cardiovascular medicine.

Research & Publications

Christopher Mallavarapu has contributed meaningfully to cardiovascular research throughout his career. He served as a PRICE trial investigator and has published peer-reviewed work in the American Heart Journal and Pacing and Clinical Electrophysiology. His research has focused on coronary artery disease, myocardial infarction, left ventricular remodeling, and platelet glycoprotein studies.

That foundation in research directly informs his clinical practice. Dr. Mallavarapu's commitment to evidence-based cardiac care means his approach to diagnosis and treatment is shaped by the latest findings in cardiovascular medicine, not just established convention.